Cargando…

Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel

Polycystic kidney disease (PKD) is the most common genetic cause of kidney failure in humans. Among the various PKD-related molecules, PKD2L1 forms cation channels, but its physiological importance is obscure. In the present study, we established a transgenic mouse line by overexpressing the dominan...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Manabu, Murakami, Agnieszka M., Nemoto, Takayuki, Ohba, Takayoshi, Yonekura, Manabu, Toyama, Yuichi, Tomita, Hirofumi, Matsuzaki, Yasushi, Sawamura, Daisuke, Hirota, Kazuyoshi, Itagaki, Shirou, Asada, Yujiro, Miyoshi, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775249/
https://www.ncbi.nlm.nih.gov/pubmed/35051185
http://dx.doi.org/10.1371/journal.pone.0261668
_version_ 1784636539982053376
author Murakami, Manabu
Murakami, Agnieszka M.
Nemoto, Takayuki
Ohba, Takayoshi
Yonekura, Manabu
Toyama, Yuichi
Tomita, Hirofumi
Matsuzaki, Yasushi
Sawamura, Daisuke
Hirota, Kazuyoshi
Itagaki, Shirou
Asada, Yujiro
Miyoshi, Ichiro
author_facet Murakami, Manabu
Murakami, Agnieszka M.
Nemoto, Takayuki
Ohba, Takayoshi
Yonekura, Manabu
Toyama, Yuichi
Tomita, Hirofumi
Matsuzaki, Yasushi
Sawamura, Daisuke
Hirota, Kazuyoshi
Itagaki, Shirou
Asada, Yujiro
Miyoshi, Ichiro
author_sort Murakami, Manabu
collection PubMed
description Polycystic kidney disease (PKD) is the most common genetic cause of kidney failure in humans. Among the various PKD-related molecules, PKD2L1 forms cation channels, but its physiological importance is obscure. In the present study, we established a transgenic mouse line by overexpressing the dominant-negative form of the mouse PKD2L1 gene (i.e., lacking the pore-forming domain). The resulting PKD2L1del-Tg mice exhibited supraventricular premature contraction, as well as enhanced sensitivity to β-adrenergic stimulation and unstable R-R intervals in electrocardiography. During spontaneous atrial contraction, PKD2L1del-Tg atria showed enhanced sensitivity to isoproterenol, norepinephrine, and epinephrine. Action potential recording revealed a shortened action potential duration in PKD2L1del-Tg atria in response to isoproterenol. These findings indicated increased adrenergic sensitivity in PKD2L1del-Tg mice, suggesting that PKD2L1 is involved in sympathetic regulation.
format Online
Article
Text
id pubmed-8775249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-87752492022-01-21 Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel Murakami, Manabu Murakami, Agnieszka M. Nemoto, Takayuki Ohba, Takayoshi Yonekura, Manabu Toyama, Yuichi Tomita, Hirofumi Matsuzaki, Yasushi Sawamura, Daisuke Hirota, Kazuyoshi Itagaki, Shirou Asada, Yujiro Miyoshi, Ichiro PLoS One Research Article Polycystic kidney disease (PKD) is the most common genetic cause of kidney failure in humans. Among the various PKD-related molecules, PKD2L1 forms cation channels, but its physiological importance is obscure. In the present study, we established a transgenic mouse line by overexpressing the dominant-negative form of the mouse PKD2L1 gene (i.e., lacking the pore-forming domain). The resulting PKD2L1del-Tg mice exhibited supraventricular premature contraction, as well as enhanced sensitivity to β-adrenergic stimulation and unstable R-R intervals in electrocardiography. During spontaneous atrial contraction, PKD2L1del-Tg atria showed enhanced sensitivity to isoproterenol, norepinephrine, and epinephrine. Action potential recording revealed a shortened action potential duration in PKD2L1del-Tg atria in response to isoproterenol. These findings indicated increased adrenergic sensitivity in PKD2L1del-Tg mice, suggesting that PKD2L1 is involved in sympathetic regulation. Public Library of Science 2022-01-20 /pmc/articles/PMC8775249/ /pubmed/35051185 http://dx.doi.org/10.1371/journal.pone.0261668 Text en © 2022 Murakami et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Murakami, Manabu
Murakami, Agnieszka M.
Nemoto, Takayuki
Ohba, Takayoshi
Yonekura, Manabu
Toyama, Yuichi
Tomita, Hirofumi
Matsuzaki, Yasushi
Sawamura, Daisuke
Hirota, Kazuyoshi
Itagaki, Shirou
Asada, Yujiro
Miyoshi, Ichiro
Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel
title Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel
title_full Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel
title_fullStr Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel
title_full_unstemmed Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel
title_short Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel
title_sort enhanced β-adrenergic response in mice with dominant-negative expression of the pkd2l1 channel
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775249/
https://www.ncbi.nlm.nih.gov/pubmed/35051185
http://dx.doi.org/10.1371/journal.pone.0261668
work_keys_str_mv AT murakamimanabu enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT murakamiagnieszkam enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT nemototakayuki enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT ohbatakayoshi enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT yonekuramanabu enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT toyamayuichi enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT tomitahirofumi enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT matsuzakiyasushi enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT sawamuradaisuke enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT hirotakazuyoshi enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT itagakishirou enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT asadayujiro enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel
AT miyoshiichiro enhancedbadrenergicresponseinmicewithdominantnegativeexpressionofthepkd2l1channel